Related Experiment Video
Updated: Feb 9, 2026

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
Published on: August 28, 2012
Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer
Tsz-Lun Yeung1, Jianting Sheng2,3, Cecilia S Leung1
1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Background:
Bulk tumor tissue samples are used for generating gene expression profiles in most research studies, making it difficult to decipher the stroma-cancer crosstalk networks. In the present study, we describe the use of microdissected transcriptome profiles for the identification of cancer-stroma crosstalk networks with prognostic value, which presents a unique opportunity for developing new treatment strategies for ovarian cancer.
Methods:
Transcriptome profiles from microdissected ovarian cancer-associated fibroblasts (CAFs) and ovarian cancer cells from patients with high-grade serous ovarian cancer (n = 70) were used as input data for the computational systems biology program CCCExplorer to uncover crosstalk networks between various cell types within the tumor microenvironment. The crosstalk analysis results were subsequently used for discovery of new indications for old drugs in ovarian cancer by computational ranking of candidate agents. Survival analysis was performed on ovarian tumor-bearing Dicer/Pten double-knockout mice treated with calcitriol, a US Food and Drug Administration-approved agent that suppresses the Smad signaling cascade, or vehicle control (9-11 mice per group). All statistical tests were two-sided.
Results:
Activation of TGF-β-dependent and TGF-β-independent Smad signaling was identified in a particular subtype of CAFs and was associated with poor patient survival (patients with higher levels of Smad-regulated gene expression by CAFs: median overall survival = 15 months, 95% confidence interval [CI] = 12.7 to 17.3 months; vs patients with lower levels of Smad-regulated gene expression: median overall survival = 26 months, 95% CI = 15.9 to 36.1 months, P = .02). In addition, the activated Smad signaling identified in CAFs was found to be targeted by repositioning calcitriol. Calcitriol suppressed Smad signaling in CAFs, inhibited tumor progression in mice, and prolonged the median survival duration of ovarian cancer-bearing mice from 36 to 48 weeks (P = .04).
Conclusions:
Our findings suggest the feasibility of using novel multicellular systems biology modeling to identify and repurpose known drugs targeting cancer-stroma crosstalk networks, potentially leading to faster and more effective cures for cancers.
Insights
This study used microdissected transcriptomes to identify ovarian cancer-stroma crosstalk networks. Repurposing calcitriol to target cancer-associated fibroblast Smad signaling improved survival in mice, suggesting new treatment strategies.
Area of Science:
- Oncology
- Systems Biology
- Cancer Research
Background:
- Bulk tumor tissue analysis hinders deciphering of stroma-cancer crosstalk networks.
- Microdissected transcriptome profiling offers a novel approach to identify prognostic cancer-stroma interactions.
- This method presents opportunities for developing new ovarian cancer treatment strategies.
Purpose of the Study:
- To identify cancer-stroma crosstalk networks with prognostic value in ovarian cancer using microdissected transcriptome profiles.
- To discover new therapeutic indications for existing drugs by analyzing these crosstalk networks.
- To investigate the potential of targeting cancer-associated fibroblast (CAF) signaling pathways.
Main Methods:
- Generated transcriptome profiles from microdissected ovarian cancer cells and CAFs from 70 high-grade serous ovarian cancer patients.
- Utilized the CCCExplorer computational systems biology program to uncover crosstalk networks within the tumor microenvironment.
- Performed survival analysis in mice treated with calcitriol, targeting Smad signaling, versus a vehicle control.
Main Results:
- Identified activated TGF-β-dependent and -independent Smad signaling in a CAF subtype, associated with significantly poorer patient survival (15 vs. 26 months median overall survival).
- Demonstrated that calcitriol effectively suppressed Smad signaling in CAFs.
- Showed that calcitriol treatment inhibited tumor progression and prolonged median survival in mice from 36 to 48 weeks.
Conclusions:
- Multicellular systems biology modeling can effectively identify drug targets within cancer-stroma crosstalk networks.
- Repurposing known drugs, like calcitriol, targeting these networks offers a feasible strategy for cancer treatment.
- This approach holds promise for accelerating the development of more effective cancer cures.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
11:51Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis
Published on: November 18, 2019
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Random and Systematic Errors
Systematic Sampling Method
Systematic sampling is one of the simplest methods...
Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
Propagation of Uncertainty from Systematic Error